The diagnostic model statistically segregated BPH from PCa patients (AUC 0.84) and predicted biopsy results better than PSA alone (AUC 0.66 and 0.527, respectively) for subjects with PSA lying in the grey area. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.